Blog Posts

Single Window Initiative (SWI): Survival guide for Health Canada Veterinary Drugs

Posted by Canadian Customs Dept. - Cole International on Mar 31, 2021 9:00:00 AM

The new SWI landscape

The Single Window Initiative means several changes for importers:

  • how you need to submit documentation is in flux;
  • when that documentation is needed has changed; and
  • which documentation is required is also shifting.SWI_Series_03_2019

Our goal is to help you understand what is expected for the new “how, when, and what” of SWI requirements relating to the items you ship. These updates guide importers through specific commodities or categories of commodities, and the Participating Government Agencies (PGAs) that are affected.

How, when, and what

  • Single Window Initiative requires all import documentation to be prepared and submitted before the shipment reaches customs.
  • SWI is a new way of submitting documentation. All docs will be submitted using the Integrated Import Declaration (IID). Some of the requirements for how you submit are changing. For example: some documents that needed to be faxed now require an uploaded electronic image or just the document number.
  • There may be changes to which documents are required under SWI.
  • The launch date of SWI is still unknown, but it’s time to get proactive and adjust your workflow to ensure paperwork is ready before you ship.

Why importers need to know

Under the new SWI, it’s important that you understand which Participating Government Agencies (PGAs) are regulating your products. Some products are regulated by multiple PGAs, and the PGAs regulating your products may have changed under SWI. Additionally, each PGA and the CBSA can issue penalties for incorrect and missing documents. Understanding what information and documentation is needed for clearance will make the clearance process into Canada smoother and more efficient.

Health Canada - Veterinary Drugs

SWI_Computer_Series_Veterinary Drugs

The SWI data elements required for release include:

Intended end use

For Health Canada’s Veterinary Drugs program, intended end use must be provided.  

  • Veterinary therapeutic use
  • Veterinary experimental study
  • Veterinary emergency drug release (EDR)
  • Veterinary clinical study
  • Research & development
  • Other

Canadian product category and required documents

A Canadian product category for veterinary drugs must be indicated. Depending on the end use, additional details and documents may be required.

  • Veterinary drug
  • Veterinary drug - low risk

Veterinary drugs with an end use of veterinary therapeutic use

  • Veterinary drug: establishment license and drug identification
  • Veterinary drug - low risk: veterinary notification

Veterinary drugs with an end use of veterinary experimental study

  • Veterinary drug: experimental studies certificate

Veterinary drugs with an end use of veterinary emergency drug release (EDR)

  • Veterinary drug: emergency drug release authorization

Veterinary drugs with an end use of veterinary clinical study

  • Veterinary drug: veterinary no objection letter (NOL)

Veterinary drugs with an end use of research & development, or other

  • Veterinary drug: no documentation required

Document reference

Veterinarian_drugs_155052386_s

Although a copy of the documents are not mandatory at time of release, it is strongly suggested to provide an image.

  • Establishment licence (EL): establishment licence number
  • Drug identification (DI): drug identification number (DIN)
  • Veterinary notification: veterinary notification number (NN)
  • Experimental studies certificate: experimental studies certificate number
  • Emergency drug release authorization: emergency drug release authorization number
  • Veterinary no objection letter (NOL): veterinary no objection letter (NOL)

Brand name

The brand name of the commodity must be provided.

Although the below elements are not mandatory for the release of the commodity, they may be asked for and should be supplied.

  • Manufacture date
  • Batch/lot number
  • Global trade identification number (GTIN)
  • Natural health products can be identified through their GTIN GS1 asset identifier or UDI Number. GTIN number is not required to be submitted, but will give CBSA a clearer identification of the product.

For SWI, being proactive is your best strategy—gather all your information and documentation as far in advance as possible. Importers who know the requirements for the products they’re importing, and understand the new processes under SWI, will have a much smoother import experience.

As you adjust to the new requirements and workflow of the Single Window Initiative, we're here to help. Our customs team is ready to help you understand the SWI and its new requirements for your commodities—contact us today!

Speak to our SWI Support Team

SWI. It's what we do